CLGN
CollPlant Biotechnologies Ltd New (CLGN)
Healthcare • NASDAQ • $0.40+2.37%
- Symbol
- CLGN
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Price
- $0.40
- Daily Change
- +2.37%
- Market Cap
- $5.80M
- Trailing P/E
- N/A
- Forward P/E
- -1.03
- 52W High
- $4.98
- 52W Low
- $0.27
- Analyst Target
- N/A
- Dividend Yield
- N/A
- Beta
- 0.64
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on its recombinant human collagen (rhCollagen) that is produced using its proprietary technology. The company offers regenerative dermal and soft tissue fillers; 3D-bioprinted regenerative breast implants; Collage, a combinant human Collagen type I solution; VergenixSTR, a soft tissue matrix for the treatment of tendinopathy; and VergenixFG, a wound care product for the treatment of deep surgical incisions and deep wounds. It also provides rhcollagen-based commercial bioink for regenerative medicine applications, such as Collink.3D 5…
Company websiteResearch CLGN on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.